breast cancer - triple negative | ||
es-BC - TNBC - NA - all population | es-BC - TNBC - NA - PDL1 positive | |
atezolizumab plus nab-paclitxel followed by doxorubicin plus cyclophosphamide | IMpassion-031 ... | IMpassion-031 ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -